Pharma Connect Capital

Groningen, Netherlands
Venture Capital
Active
Total investments

1

Portfolio companies

1

Lead investments

1

Areas of investment
BiotechnologyLife ScienceBiopharma

Investor highlights

Industry focus
Biotech/Life SciencesMedtech
Stage focus
Series ASeries B
Geo focus

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
1
Lead investments
1
Investments by industry
  • Biotechnology (1)
  • Biopharma (1)
  • Life Science (1)
Investments by region
  • The Netherlands (1)
Peak activity year
2024

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
2

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Sabiad08 Jan 2024Biotechnology, Life Science, BiopharmaSeedHeerenveen, Friesland, The Netherlands
Company nameDeal dateIndustryDeal stageDeal sizeLocation
EquixlyDec 9, 2025AI, API Security, Cybersecurity, Scalable Product-10000000 EUR Florence, Tuscany
AcoruOct 22, 2025AI, Banking, Fraud Prevention, Money Laundering Prevention-10000000 EUR Madrid,
StrikeReadySep 4, 2024AI, Cybersecurity-12000000 USD Dallas, Texas
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.